Skip to main content
Erschienen in: European Radiology 4/2005

01.04.2005 | Pediatric

Pediatric brain MRI in neurofibromatosis type I

verfasst von: Hans-J. Mentzel, Jörg Seidel, Clemens Fitzek, Annegret Eichhorn, Susanna Vogt, Jürgen R. Reichenbach, Felix Zintl, Werner A. Kaiser

Erschienen in: European Radiology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Neurofibromatosis (NF) is the most common of the phakomatoses, with a prevalence of 1 in 3–4,000. Many organ systems can be affected. In addition to multiple peripheral neurofibromas, NF I predisposed to CNS tumors including optic glioma, astrocytoma and plexiform neurofibroma. The purpose of this pictorial review is to illustrate characteristic brain MR imaging lesions in children with NF I and to give some recommendations about diagnostic imaging procedures in children suffering from NF I. Typical findings in brain MRI are hyperintense lesion on T2-weighted images, so-called unknown bright objects, which may be useful as an additional imaging criterion for NF I. Contrast administration is necessary in MR studies to maximize tumor detection and characterization, to add confidence to the diagnosis of benign probable myelin vacuolization, and to document stability of neoplasm on follow-up examinations. We recommend to perform serial MR imaging in children every 12 months. The frequency of follow-up in children with known brain tumors will vary with the tumor grade, biological activity and treatment.
Literatur
1.
Zurück zum Zitat National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575–578 National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575–578
2.
Zurück zum Zitat Guillamo JS, Creange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P (2003) Prognostic factors of CNS tumors in neurofibromatosis 1 (NF 1). A retrospective study of 104 patients. Brain 126:152–160CrossRefPubMed Guillamo JS, Creange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P (2003) Prognostic factors of CNS tumors in neurofibromatosis 1 (NF 1). A retrospective study of 104 patients. Brain 126:152–160CrossRefPubMed
3.
Zurück zum Zitat Mukonoweshuro W, Griffiths PD, Blaser S (1999) Neurofibromatosis type 1: the role of neuroradiology. Neuropediatrics 30:111–119PubMed Mukonoweshuro W, Griffiths PD, Blaser S (1999) Neurofibromatosis type 1: the role of neuroradiology. Neuropediatrics 30:111–119PubMed
4.
Zurück zum Zitat Es SV, North KN, McHugh K, Silva MD (1996) MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 26:478–487PubMed Es SV, North KN, McHugh K, Silva MD (1996) MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 26:478–487PubMed
5.
Zurück zum Zitat Czyzyk E, Jozwiak S, Roszkowski M, Schwartz RA (2003) Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 18:471–478PubMed Czyzyk E, Jozwiak S, Roszkowski M, Schwartz RA (2003) Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 18:471–478PubMed
6.
Zurück zum Zitat Rossi LN, Triulzi F, Parazzini C, Maninetti MM (1999) Spontaneous improvement of optic pathway lesions in children with neurofibromatosis type 1. Neuropediatrics 30:205–209PubMed Rossi LN, Triulzi F, Parazzini C, Maninetti MM (1999) Spontaneous improvement of optic pathway lesions in children with neurofibromatosis type 1. Neuropediatrics 30:205–209PubMed
7.
Zurück zum Zitat Singhal S, Birch JM, Kerr B, Lashford L, Evans DG (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65–70CrossRefPubMed Singhal S, Birch JM, Kerr B, Lashford L, Evans DG (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65–70CrossRefPubMed
8.
Zurück zum Zitat Riffaud L, Vinchon M, Ragragui O, Delestret I, Ruchoux MM, Dhellemmes P (2002) Hemispheric cerebral gliomas in children with NF 1: arguments for a long-term follow-up. Childs Nerv Syst 18:43–47CrossRefPubMed Riffaud L, Vinchon M, Ragragui O, Delestret I, Ruchoux MM, Dhellemmes P (2002) Hemispheric cerebral gliomas in children with NF 1: arguments for a long-term follow-up. Childs Nerv Syst 18:43–47CrossRefPubMed
9.
Zurück zum Zitat Ilgren EB, Kinnnier-Wilson LM, Stiller CA (1985) Gliomas in neurofibromatosis: a series of 89 cases with evidence for increased malignancy in associated cerebellar astrocytomas. Pathol Ann 20:331–358 Ilgren EB, Kinnnier-Wilson LM, Stiller CA (1985) Gliomas in neurofibromatosis: a series of 89 cases with evidence for increased malignancy in associated cerebellar astrocytomas. Pathol Ann 20:331–358
10.
Zurück zum Zitat Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652–1660PubMed Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652–1660PubMed
11.
Zurück zum Zitat Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF 1 optic pathway glioma task force. Ann Neurol 41:143–149PubMed Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF 1 optic pathway glioma task force. Ann Neurol 41:143–149PubMed
12.
Zurück zum Zitat Elster AD (1992) Radiologic screening in the neurocutaneous syndromes: strategies and controversies. Am J Neuroradiol 13:1078–1082PubMed Elster AD (1992) Radiologic screening in the neurocutaneous syndromes: strategies and controversies. Am J Neuroradiol 13:1078–1082PubMed
13.
Zurück zum Zitat Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Manson G, Cheung S (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 104(4):e49PubMed Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Manson G, Cheung S (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 104(4):e49PubMed
14.
Zurück zum Zitat Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P (2000) Cerebellar gliomas in children with NF 1: pathology and surgery. Childs Nerv Syst 16:417–420PubMed Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P (2000) Cerebellar gliomas in children with NF 1: pathology and surgery. Childs Nerv Syst 16:417–420PubMed
15.
Zurück zum Zitat Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. Am J Neuroradiol 24:1678–1682PubMed Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. Am J Neuroradiol 24:1678–1682PubMed
16.
Zurück zum Zitat Meersschaut VA, Kros JM, Catsman-Berrevoets CE, Lequin MH (2003) Congenital bilateral plexiform neurofibromas of the cavernous sinuses. Pediatr Radiol 33:272–274PubMed Meersschaut VA, Kros JM, Catsman-Berrevoets CE, Lequin MH (2003) Congenital bilateral plexiform neurofibromas of the cavernous sinuses. Pediatr Radiol 33:272–274PubMed
17.
Zurück zum Zitat Raininko R, Thelin L, Eeg-Olofsson O (2001) Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1. Neuropediatrics 32:225–230CrossRefPubMed Raininko R, Thelin L, Eeg-Olofsson O (2001) Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1. Neuropediatrics 32:225–230CrossRefPubMed
18.
Zurück zum Zitat DeBella K, Poskitt K, Szudek J, Friedman JM (2000) Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54:1646–1650PubMed DeBella K, Poskitt K, Szudek J, Friedman JM (2000) Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54:1646–1650PubMed
19.
Zurück zum Zitat Wieshmann UC, Clark CA, Symms MR (1999) Reduced anistotropy of water diffusion in structural cerebral abnormalities demonstrated with diffusion tensor imaging. Magn Res Imaging 17:1269–1274CrossRef Wieshmann UC, Clark CA, Symms MR (1999) Reduced anistotropy of water diffusion in structural cerebral abnormalities demonstrated with diffusion tensor imaging. Magn Res Imaging 17:1269–1274CrossRef
20.
Zurück zum Zitat Sener RN, Dzelzite S, Migals A, Raits U, Veinbergs AA (2003) Prominent myelin vacuolization in neurofibromatosis type 2. J Clin Imaging 27:11–13CrossRef Sener RN, Dzelzite S, Migals A, Raits U, Veinbergs AA (2003) Prominent myelin vacuolization in neurofibromatosis type 2. J Clin Imaging 27:11–13CrossRef
21.
Zurück zum Zitat Mori H, Abe O, Okubo T, Hayashi N, Yoshikawa T, Kunimatsu A, Yamada H, Aoki S, Ohtomo K (2001) Diffusion property in a hamartomatous lesion of neurofibromatosis type 1. J Comput Assist Tomogr 25:537–539CrossRefPubMed Mori H, Abe O, Okubo T, Hayashi N, Yoshikawa T, Kunimatsu A, Yamada H, Aoki S, Ohtomo K (2001) Diffusion property in a hamartomatous lesion of neurofibromatosis type 1. J Comput Assist Tomogr 25:537–539CrossRefPubMed
22.
Zurück zum Zitat Eastwood JD, Fiorella DJ, MacFall JF, Delong DM, Provenzale JM, Greenwood RS (2001) Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology 219:354–358PubMed Eastwood JD, Fiorella DJ, MacFall JF, Delong DM, Provenzale JM, Greenwood RS (2001) Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology 219:354–358PubMed
23.
Zurück zum Zitat Sheikh SF, Kubal WS, Anderson AW, Mutalik P (2003) Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1. J Comput Assist Tomogr 27:681–686CrossRefPubMed Sheikh SF, Kubal WS, Anderson AW, Mutalik P (2003) Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1. J Comput Assist Tomogr 27:681–686CrossRefPubMed
24.
Zurück zum Zitat Sener RN (2002) Diffusion MRI in neurofibromatosis type a: ADC evaluations of the optic pathways, and a comparison with normal individuals. Comput Med Imaging Graph 26:59–64CrossRefPubMed Sener RN (2002) Diffusion MRI in neurofibromatosis type a: ADC evaluations of the optic pathways, and a comparison with normal individuals. Comput Med Imaging Graph 26:59–64CrossRefPubMed
25.
Zurück zum Zitat Sevick RJ, Barkovich AJ, Edwards MSB, Koch T, Berg B, Lempert T (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 159:171–175 Sevick RJ, Barkovich AJ, Edwards MSB, Koch T, Berg B, Lempert T (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 159:171–175
26.
Zurück zum Zitat Aoki S, Barkovich AJ, Nishimura K, Kjos BO, Machida T, Cogen P, Edwards M, Norman D (1989) Neurofibromatosis types 1 & 2: cranial MR findings. Radiology 172:527–534PubMed Aoki S, Barkovich AJ, Nishimura K, Kjos BO, Machida T, Cogen P, Edwards M, Norman D (1989) Neurofibromatosis types 1 & 2: cranial MR findings. Radiology 172:527–534PubMed
27.
Zurück zum Zitat Terada H, Barkovich AJ, Edwards MSB, Cercillo SF (1996) Evolution of high-intensity basal ganglia lesions on T1 weighted MR in neurofibromatosis type 1. Am J Neuroradiol 17:755–760PubMed Terada H, Barkovich AJ, Edwards MSB, Cercillo SF (1996) Evolution of high-intensity basal ganglia lesions on T1 weighted MR in neurofibromatosis type 1. Am J Neuroradiol 17:755–760PubMed
28.
Zurück zum Zitat Legius E, Descheemaeker MJ, Steyaert J, Spaepen A, Vlietinck R, Casaer P, Demaerel P, Fryns JP (1995) Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry 59:635–640PubMed Legius E, Descheemaeker MJ, Steyaert J, Spaepen A, Vlietinck R, Casaer P, Demaerel P, Fryns JP (1995) Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry 59:635–640PubMed
29.
Zurück zum Zitat Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM (1996) Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660–1668PubMed Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM (1996) Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660–1668PubMed
30.
Zurück zum Zitat Hyman SL, Gill DS, Shores EA, Steinberg A, Joy P, Gibikote SV, North KN (2003) Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF 1. Neurology 60:1139–1145PubMed Hyman SL, Gill DS, Shores EA, Steinberg A, Joy P, Gibikote SV, North KN (2003) Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF 1. Neurology 60:1139–1145PubMed
31.
Zurück zum Zitat Pinson S, Creange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, Sanson M, Bernheim A, d’Incan M, Doz F, Stoll C, Combemale P, Kalifa C, Zeller J, Teillac-Hamel D, Lyonnet S, Zerah M, Lacour JP, Guillot B, Wolkenstein P (2002) Neurofibromatosis 1: recommendations for management. Arch Pediatr 9:49–60CrossRefPubMed Pinson S, Creange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, Sanson M, Bernheim A, d’Incan M, Doz F, Stoll C, Combemale P, Kalifa C, Zeller J, Teillac-Hamel D, Lyonnet S, Zerah M, Lacour JP, Guillot B, Wolkenstein P (2002) Neurofibromatosis 1: recommendations for management. Arch Pediatr 9:49–60CrossRefPubMed
Metadaten
Titel
Pediatric brain MRI in neurofibromatosis type I
verfasst von
Hans-J. Mentzel
Jörg Seidel
Clemens Fitzek
Annegret Eichhorn
Susanna Vogt
Jürgen R. Reichenbach
Felix Zintl
Werner A. Kaiser
Publikationsdatum
01.04.2005
Erschienen in
European Radiology / Ausgabe 4/2005
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-004-2433-y

Weitere Artikel der Ausgabe 4/2005

European Radiology 4/2005 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.